Frontiers journals are at the top of citation and impact metrics
Cardiovascular and Smooth Muscle Pharmacology aims to publish research related to the pharmacotherapy of cardiovascular disorders and those of other smooth muscle-rich organs, such as functional disorders of the heart, blood vessels, kidneys and urinary tract, as well as the central nervous system.
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
PMCID: all published articles receive a PMCID
Cardiovascular and Smooth Muscle Pharmacology welcomes submissions of the following article types: Book Review, Brief Research Report, Case Report, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Technology and Code.
All manuscripts must be submitted directly to the section Cardiovascular and Smooth Muscle Pharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Cardiovascular and Smooth Muscle Pharmacology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org